Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have end-stage kidney disease (where the kidneys have stopped working properly) and who also have a serious blood infection (sepsis), with a specific protein linked to inflammation (interleukin-6) measured above a certain level in their blood
Who may not be able to join:
- People who require a specific type of continuous kidney support treatment (called continuous kidney replacement therapy), people considered vulnerable such as pregnant women, or people whose doctors expect them to pass away within 24 hours
- People who have previously had an allergic reaction to the type of dialysis filter (dialyzer) being used in this trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Punnawit Laungchuaychok, MD, Navamindradhiraj University
Phone: 022443000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Comparing the reduction of all cause death at 28 days
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.